FAM
IPXL

Fred Alger Management’s Impax Laboratories, Inc. IPXL Stock Holding History

Fred Alger Management’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-63,252
Closed -$1.82M – 556
2016
Q2 		$1.82M Sell
63,252
-15,934
-20% -$519K 0.01% 280
2016
Q1 		$2.54M Sell
79,186
-6,466
-8% -$227K 0.01% 310
2015
Q4 		$3.66M Sell
85,652
-64,020
-43% -$2.56M 0.02% 284
2015
Q3 		$5.27M Sell
149,672
-58,660
-28% -$2.64M 0.03% 261
2015
Q2 		$9.57M Buy
+208,332
New +$9.89M 0.04% 233

Other funds holding IPXL

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fred Alger Management's IPXL Position: Q3 2016 in Review

Fred Alger Management sold out of Impax Laboratories, Inc. (IPXL) in Q3 2016, closing a stake of 63,252 shares — an estimated $1.82M sold.

Fred Alger Management first reported a position in IPXL in Q2 2015 and held it in 5 quarters. The position peaked at $9.57M in Q2 2015. 196 funds tracked by Wall St. Rank hold IPXL as of Q3 2016.

  • Fred Alger Management reported no remaining Impax Laboratories, Inc. position as of Q3 2016 after selling out during the quarter.
  • Fred Alger Management sold 63,252 Impax Laboratories, Inc. shares in Q3 2016, an estimated $1.82M.
  • Fred Alger Management first reported a position in Impax Laboratories, Inc. in Q2 2015 and held it in 5 quarters.
  • Fred Alger Management's Impax Laboratories, Inc. position peaked at $9.57M in Q2 2015.
  • 196 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q3 2016.

Based on Fred Alger Management's 13F filing for Q3 2016, filed 14 Nov 2016.